Geometry Dash APK Hill Climb Racing APK
18.5 F
New York
Thursday, January 27, 2022

The Spark of Life in GB Sciences Inc (OTCMKTS:GBLX)?

Must read

Medmen Enterprises Inc (OTCMKTS:MMNFF) Pulls Back From Highs as Buzz Cools Off

Among the sectors which have bounced back in 2021, the cannabis sector is one of considerable interest since it had been in...

VirtualArmour International Inc (OTCMKTS:VTLR) Jumps Another 250% This Week

Not every move in the stock market can always be explained and hence, investors are often rightly confused when a stock records...

Ozop Energy Solutions Inc (OZSC) is Riding a Green Wave of Momentum

Investors who are looking for fresh opportunities in rising stocks may have a lot to choose from at this point but it...

Drone Delivery Canada Corp (OTCMKTS:TAKOF) is Soaring after Roadmap Update

The drone industry has grown at a remarkable rate over the past five years or so and hence, it is no surprise...

Left out thus far in the cannabis-related bonanza that has gripped markets over the past 6 weeks is GB Sciences Inc (OTCMKTS:GBLX). The stock is often a late bloomer, but a potentially big bloomer when it starts running. At this point, the stock is starting to spark to life a bit, helped by its recent announcement that it has been granted a recreational production license for the manufacture of cannabis oils.

According to the release, “Oils are the base ingredient for vape products, tinctures, edibles, and nutraceutical formulations. The Company received its medical marijuana production license on February 2, 2018. The State of Nevada instructed them to apply for the recreational license in June, for upgraded licenses. The Company’s anticipated revenues from extracted and infused products were delayed by six months. Now, with the issuance of the recreational oil production license, the Company can begin selling its tinctures, oils, vape pens and edibles with estimated revenue starting at around $100,000 per month and growing to at least $300,000 per month.”

GB Sciences Inc (OTCMKTS:GBLX) as a company that seeks to be an innovative technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a variety of ailments.

The Company is developing and utilizing state of the art technologies in plant biology, cultivation and extraction techniques, combined with biotechnology, and plans to produce consistent and measurable medical-grade cannabis, cannabis concentrates and cannabinoid therapies.

“Although we believe that maximum shareholder value will ultimately be achieved through the development, production, and marketing of certified cannabinoid medicines, therapies and treatments, in order to generate cash flow and near-term profitability, we intend to cultivate and dispense cannabis for medical purposes in both Nevada and other states which permit such sales and in which we and our operating partners are able to obtain cultivation and dispensing licenses. We seek to become a trusted producer of consistent and efficacious medicinal strains and products, combining both cannabinoids and terpenes, which we intend to market in those states within the United States and in other countries where the sale of medical cannabis products are permitted. In addition, subject to obtaining Food and Drug Administrative (FDA) certification, we intend to market our cannabinoid-based drug discoveries on a worldwide basis.”

GBLX claims to produce measurable medical-grade cannabis, cannabis concentrates, and cannabinoid therapies through using various technologies in plant biology, cultivation, and extraction techniques combined with biotechnology.

It also claims to be involved in the development of controlled-climate indoor agricultural technology growing and cultivation suites, including TissueBLOX, GrowBLOX, CureBLOX, and ExtractionLAB.

According to additional company materials, “GB Sciences, Inc. (GBLX) is a diverse cannabis company, focused on cultivation as well as biopharmaceutical research and development. The Company’s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions.”

Find out when $GBLX stock reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

“We have spent a lot of time, care and effort in selecting and cultivating the best genetics for their natural abilities to deal with specific disease conditions. Now whole plant extraction without using solvents allow us to complete the delivery on our promise… pure, consistent, and trusted raw ingredients in everything we do. We have planned on this opportunity for a long time. And now that it’s here, we can’t wait to get started.”

We’ve witnessed 35% during the past week in terms of shareholder gains in the listing, but that move comes in the context of a larger bearish trend. In addition, the name has witnessed a pop in interest, as transaction volume levels have recently pushed 120% beyond what we have been seeing over the larger time frame.

CEO and Chairman of the Board, John Poss, states, “This is a great opportunity to spread our core scientific approach to multiple new retail products. Our core tenets of purity, consistency and trust can now truly extend from seed to sale across multiple lines of cannabis products. It is the first step in building and introducing a national, trusted brand family. This is a true inflection point in the growth of GB Sciences.”

Now commanding a market cap of $82.76M, GBLX has a significant war chest ($4.7M) of cash on the books, which compares with about $2M in total current liabilities. One should also note that debt has been growing over recent quarters. GBLX is pulling in trailing 12-month revenues of $3.6M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 2331.3%. This may be a very interesting story and we will look forward to updating it again soon. Sign-up for continuing coverage on shares of $GBLX stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $GBLX, either long or short, and we have not been compensated for this article.

Latest article

iQSTEL Inc (OTCMKTS:IQST) Stock Makes a Big Move: Jumps 45% In a Week

In the past week, iQSTEL Inc (OTCMKTS: IQST) has emerged as a point of focus among a large number of investors and...

HUMBL Inc (OTCMKTS:HMBL) Stock Sees Big Bounce After Recent Slump

Since the beginning of 2021, HUMBL Inc (OTCMKTS:HMBL) had been one of the major movers from among penny stocks and had come into...

Dividend Stocks to Buy Now

A classic mistake that investors make when looking for dividend stocks is to just go for the biggest dividend yield. It makes...

88 Energy Ltd (OTCMKTS:EEENF) Stock Surges 40% But Can’t Hold Gains

The oil and gas company 88 Energy Ltd (OTCMKTS:EEENF) seems to have come back on to the radars of investors over the...

Net Savings Link Inc (OTCMKTS:NSAV) Stock is Getting Pummeled Again

Nowadays there are plenty of options for investors when it comes to making investments in the cryptocurrency and...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet. Affordable best sms verification service